| Old Articles: <Older 7221-7230 Newer> |
 |
BusinessWeek March 6, 2006 |
The Big Man at the Big Board NYSE chief John Thain talks about going global, going public, going electronic, and bringing the exchange into the 21st century.  |
HBS Working Knowledge February 27, 2006 Martha Lagace |
Corporate Values and Employee Cynicism Positive values are a fixture on corporate mission statements these days. But when leaders fail to live up to the values they've articulated, it's a recipe for employee cynicism.  |
HBS Working Knowledge February 27, 2006 Sean Silverthorne |
When Rights of First Refusal Are a Bad Deal Common in such industries as entertainment, contracts that include a right of first refusal usually benefit the holder of that right. But not always. New research by Harvard professor Alvin E. Roth and colleague Brit Grosskopf explains when it's wise to say no.  |
HBS Working Knowledge February 27, 2006 Cohn, Khurana & Reeves |
Take Responsibility for Rising Stars Many executives believe that leadership development is a job for the HR department. This may be the single biggest misconception they can have.  |
HBS Working Knowledge February 27, 2006 Jim Heskett |
Summing Up: Should CEOs of Public Companies Offer Earnings Guidance? Readers weigh in: Anyone who has stock or investments in a public company should be privileged to certain short-term information... Employees feel pressure to have the business look good on a quarterly basis... etc.  |
The Motley Fool February 27, 2006 Alyce Lomax |
Amazon Shopbops Till It Drops? The timing of Amazon's acquisition of Shopbop.com seems odd, especially after the company reported a quarter that left many investors cold, and especially since it's a departure from Amazon's usual acquisition strategy. Investors, take note.  |
The Motley Fool February 27, 2006 Rick Aristotle Munarriz |
Ask, the World Turns Ask.com starts a new life with Jeeves riding off into the sunset. But losing the edge of Jeeves won't matter if the company is able to put its many dot-com puzzle pieces together. Investors, take note.  |
Bio-IT World February 2006 Kevin Davies |
Celera Drops Drugs for Diagnostics The company that raced to sequence the human genome, ditched its flamboyant CEO and database subscription model to become a drug development company, has decided to change course yet again.  |
Bio-IT World February 2006 John Russell |
Inside BG Medicine Think Intel Inside, but instead of microprocessors, think industrial-strength experimental platforms, focused on all things omic, designed and even run by a third party, but living deep inside biopharmaceutical companies. This is BM Medicine's CEO Pieter Muntendam's strategy.  |
BusinessWeek March 6, 2006 Brian Grow |
Renovating Home Depot Home Depot is thriving under CEO Bob Nardelli's military-style rule.  |
| <Older 7221-7230 Newer> Return to current articles. |